Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05111015 · ClinicalTrials.gov registry record

Tracking Results of Ablations to Combat AF Registry Generation 2

A clinical trial of Atrial Fibrillation, sponsored by AtriCure.

Recruiting
Registry status
10,000
Enrollment target
20
Study locations

NCT05111015 is a study of Atrial Fibrillation that is actively recruiting participants, run by AtriCure. The registered enrollment target is 10,000 participants, above the 2,947-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (239% higher). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05111015, a study of Atrial Fibrillation, is actively recruiting participants, sponsored by AtriCure.

RECRUITING
Registry status
10,000 participants
Enrollment target
20
Study locations

Study Summary

The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

Conditions Studied

Atrial Fibrillation

Interventions

  • DEVICE Open Concomitant Surgical Ablation Procedures
  • DEVICE Hybrid (Convergent) Ablation Procedures
  • DEVICE AtriCure Hybrid Totally Thoracoscopic Ablation Procedures
  • DEVICE AtriCure LAA Exclusion Procedures

Study Locations (20)

Florida

  • Delray Medical Center - Delray Beach
  • University of Florida - Gainesville
  • Orlando Health Heart & Vascular Institute - Orlando
  • St. Joseph's Hospital (BayCare) - Tampa

Arkansas

  • St. Bernards Medical Center - Jonesboro
  • CHI St. Vincent Heart Institute - Little Rock

California

  • Loma Linda University Medical Center - Loma Linda
  • Adventist Heart Institute (St. Helena Hospital) - St. Helena

Michigan

  • University of Michigan - Ann Arbor
  • Corewell Health - Grand Rapids

New York

  • Maimonides Health Heart & Vascular Institute - Brooklyn
  • Vassar Brothers Medical Center - Poughkeepsie

Alabama

  • Huntsville Hospital - Huntsville

Colorado

  • Valley View Hospital - Glenwood Springs

District of Columbia

  • MedStar Washington Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2013-02
Est. Completion 2030-01

Sponsor

AtriCure

23 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05111015

The ClinicalTrials.gov registry entry for NCT05111015 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,947-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (239% higher). The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 4 interventions - of which Open Concomitant Surgical Ablation Procedures is the first listed.

NCT05111015 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Arkansas, California.

Frequently Asked Questions

What is clinical trial NCT05111015 about?

NCT05111015 is a clinical study titled "Tracking Results of Ablations to Combat AF Registry Generation 2". The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

What is the current status of trial NCT05111015?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2013-02. Estimated completion is 2030-01.

What conditions does trial NCT05111015 study?

This clinical trial studies the following conditions: Atrial Fibrillation.

What interventions are being tested in trial NCT05111015?

The interventions under investigation include: Open Concomitant Surgical Ablation Procedures (DEVICE), Hybrid (Convergent) Ablation Procedures (DEVICE), AtriCure Hybrid Totally Thoracoscopic Ablation Procedures (DEVICE), AtriCure LAA Exclusion Procedures (DEVICE).

Who is sponsoring clinical trial NCT05111015?

This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05111015 being conducted?

This trial has 20 study locations across Alabama, Arkansas, California, Colorado, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Atrial Fibrillation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Atrial Fibrillation

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.